Latest Articles

Publication Date
Expanding the genetic landscape of endometriosis: Integrative -omics analyses implicate key genes and pathways in a multi-ancestry study of over one million women.

We report the findings of a genome-wide association study (GWAS) meta-analysis of endometriosis across 14 biobanks worldwide, including 32% non-European patient participants, as part of ​the ​Global Biobank Meta-Analys​i​s Initiative​ …

Published: Dec. 4, 2025, midnight
Ethanol sclerotherapy for endometriomas: a fertility-preserving alternative.

Endometriomas are a common manifestation of endometriosis in women of reproductive age and pose a clinical challenge due to their association with pain, infertility, and compromised ovarian reserve. Surgical removal …

Published: Dec. 4, 2025, midnight
'Inappropriate': Experts caution against taking medical advice from influencers - 9News.com.au

'Inappropriate': Experts caution against taking medical advice from influencers 9News.com.au

Published: Dec. 3, 2025, 11:54 p.m.
Self-Harm Risk Elevated Following Endometriosis Diagnosis - Medscape

Self-Harm Risk Elevated Following Endometriosis Diagnosis Medscape

Published: Dec. 3, 2025, 8:16 p.m.
Newstalk ZB host Tyler Adams and partner Maeve open up about their fertility journey - Now to Love NZ

Newstalk ZB host Tyler Adams and partner Maeve open up about their fertility journey Now to Love NZ

Published: Dec. 3, 2025, 8 p.m.
Molly Qerim speaks out after shocking First Take exit, stands firmly by friend facing serious legal troub - The Times of India

Molly Qerim speaks out after shocking First Take exit, stands firmly by friend facing serious legal troub The Times of India

Published: Dec. 3, 2025, 5:09 p.m.
Molly Qerim speaks out after shocking First Take exit, stands firmly by friend facing serious legal troub - Times of India

Molly Qerim speaks out after shocking First Take exit, stands firmly by friend facing serious legal troub Times of India

Published: Dec. 3, 2025, 5:09 p.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - BioSpace

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia BioSpace

Published: Dec. 3, 2025, 2:11 p.m.
United States GnRH Agonists and Antagonists Drugs - openPR.com

United States GnRH Agonists and Antagonists Drugs openPR.com

Published: Dec. 3, 2025, 7:24 a.m.
United States Endometriosis Treatment Market Size, Share, - openPR.com

United States Endometriosis Treatment Market Size, Share, openPR.com

Published: Dec. 3, 2025, 6:59 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!